Fig. 1From: Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studiesFlow diagram of study identification and selection process. Note: No additional study was identified by checking reference lists of included studies. Some studies contributed to more than one drug-drug comparisonBack to article page